Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JP4408612B2 - New acetylene compounds - Google Patents
[go: Go Back, main page]

JP4408612B2 - New acetylene compounds - Google Patents

New acetylene compounds Download PDF

Info

Publication number
JP4408612B2
JP4408612B2 JP2002245569A JP2002245569A JP4408612B2 JP 4408612 B2 JP4408612 B2 JP 4408612B2 JP 2002245569 A JP2002245569 A JP 2002245569A JP 2002245569 A JP2002245569 A JP 2002245569A JP 4408612 B2 JP4408612 B2 JP 4408612B2
Authority
JP
Japan
Prior art keywords
compounds
bidens
methanol
group
nmr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP2002245569A
Other languages
Japanese (ja)
Other versions
JP2004083463A (en
JP2004083463A5 (en
Inventor
草野源次郎
草野昭子
瀬山義幸
Original Assignee
株式会社武蔵野免疫研究所
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 株式会社武蔵野免疫研究所 filed Critical 株式会社武蔵野免疫研究所
Priority to JP2002245569A priority Critical patent/JP4408612B2/en
Publication of JP2004083463A publication Critical patent/JP2004083463A/en
Publication of JP2004083463A5 publication Critical patent/JP2004083463A5/ja
Application granted granted Critical
Publication of JP4408612B2 publication Critical patent/JP4408612B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Description

【0001】
【産業上の利用分野】
本発明は血糖低下及び抗炎症作用を有する保健上有用な化合物に関する。
【従来の技術】
【0002】
糖尿病は生活習慣病の一つであり患者は予備軍を含めると日本に1470万人とも言われる大衆病である。また炎症は、ウイルスや細菌による感染を始め外傷、打撲などの手術などの侵襲に対する生体防御反応の一環として起こる正常反応であるが一方では発熱・疼痛・腫脹・機能障害を伴い治療上これを抑制する必要がしばしば起こってくる。
【0003】
いずれもこれまで天然物からの検索や合成医薬品として血糖低下作用や抗炎症作用に優れた薬物が多数知られており、また実用にも供されているがより優れたものを求める探索努力が各方面において地道に継続されている。
【発明が解決しようとする課題及び課題を解決するための手段】
【0004】
発明者等は、安全性に優れ、かつこれらの目的に適した植物を対象に探索を進め、既に民間伝承薬として広く利用されているセンダングサ属の植物から血糖低下作用や抗炎症作用に優れた化合物を検索することによって、新しい血糖降下剤や抗炎症剤を提供しようとするものである。
【0005】
本発明の化合物は、キク科センダングサ属植物のBidens pilosaから発見された文献未載の新規化合物である。Bidens pilosaで代表されるキク科センダングサ属植物は、特願2000−105559に詳述したように、種類も多岐に亘り互いに交配するので変種も多く、植物学上も混乱が見られ、学名、和名、漢名、の対応も交錯していて同定することは極めて困難であるが、本発明で用いられるセンダングサ属植物は以下に掲げるものを包含する。
【0006】
Bidens pilosa L.(コセンダングサ、コシロノセンダングサ、咸豊草)
Bidens pilosa L.var.minor(Blume)Sherff(シロバナセンダングサ、シロノセンダングサ、コシロノセンダングサ、コセンダングサ、咸豊草)
Bidens pilosa L.var.bisetosa Ohtani et Suzuki(アワユキセンダングサ)
Bidens pilosa L.f.decumbens Scherff(ハイアワユキセンダングサ)
Bidens pilosa L.var.radiata Scherff(タチアワユキセンダングサ、ハイアワユキセンダングサを含むこともある)
Bidens pilosa L.var.radiata Schultz Bipontinus(シロノセンダングサ、オオバナノセンダングサ)
Bidens biternata Lour.Merrill et Scherff(センダングサ)
Bidens bipinnata L.(コバノセンダングサ、センダングサ)
Bidens cernua L.(ヤナギタウコギ)
Bidens frondosa L.(アメリカセンダングサ、セイタカタウコギ)
Bidens parviflora Willd(ホソバノセンダングサ)
Bidens radiata Thuill.var.pinnatifida (Turcz.)Kitamura(エゾノタウコギ)
Bidens tripartita L.(タウコギ)
【0007】
この植物は中国・台湾では主に咸豊草と呼ばれるが異名も多く、同治草、鬼針草、三葉鬼針草、三葉刺針草、刺針草、婆婆針草、白花婆婆針、蝦箝草、符因草、符因頭、赤査某、金盞銀盤、含風草、南風草、蝦公鋏、羞査某仔等の名があり、それぞれがどの学名に相当するのかは明らかでない。
【0008】
花はキク科特有の形で、白色または黄色の丸みのある花弁のような舌状花が数個、中央には黄褐色の管状花が多数集合している。中には舌状花を欠くものもある。茎は四角で薄紫に着色した節がある。3つまたは5つに羽状に分かれた葉には柄があり、縁にはぎざぎざがあって対生しているものが多い。
【0009】
日本では本州の暖地以南で見られ、台湾、中国ないし世界の亜熱帯ないし熱帯各地に分布し、草丈は25cm〜約1mにもなり、通常一年草であるが温暖な気候条件に恵まれると越冬し、花は一年中次々と咲く。動物や人の衣服に付いて運ばれる黒褐色の種子の上部に逆棘のある針があり、針の数も交配のため一定しないものが多い。中国では鬼針草属と呼ばれている。
【0010】
センダングサ属植物とくにBidens pilosaは古来伝承薬として経験的に、全草が糖尿病や炎症性疾患、各種消化器病、各種感染症、リウマチ、等の治療に、アフリカ、中南米、アジア等世界の熱帯〜温帯地域で広く使われてきた。例えば台湾では急・慢性虫垂炎、腎炎、胃腸炎、下痢、インフルエンザ、咽頭炎、歯痛、肝炎、十二指腸炎に広く用いられ、肝臓の保護作用があるとされている。アフリカでは傷の治療や重症悪阻(おそ)、胃痛、便秘、腸内寄生虫、赤痢、下痢、腹痛等に使われてきた。葉の搾汁は火傷や結膜炎、耳炎、さらに止血剤にも用いるという。磨砕した汁や根の料理はマラリアに効くと言われ、ズールー族では新芽を噛んでリウマチの薬としている。中国では腸炎、桿菌赤痢、咽頭炎に使われ、この植物を砕きあるいは煎じて傷の治療や慢性潰瘍に使用される。中央アメリカの島々では搾汁を目薬に、ベネズエラやブラジルでは潰瘍に、ボリビアのアンデスでは血圧を下げるのに使う。また利尿や胆汁分泌促進、風疹や猩猴熱の解熱にも用いる。
【0011】
発明者等はこれほど使用経験の豊富な、従って安全性に優れた本植物のエキスにつき、ヒトの糖尿病、高脂血症、アトピー性皮膚炎、肝炎、下肢に生じる難治性夏季潰瘍、等に特に効果を認め、また動物実験によっても繰返しその効果を裏付ける結果を得たことから、本植物に含まれる各種化合物を分画し、その単離精製を試み3種の新規化合物の発見に至ったものである。
【0012】
【測定用機器】
紫外部スペクトル:島津分光光度計UV12008
赤外部スペクトル:Perkin−Elmer1720X−FTIE分光計
MSスペクトル:日立M−80分光計
NMRスペクトル:Varian Mercury 300、及びunityInova−500(溶媒:CDCl3 、CD3 OD、及びpyridine−d5 、内部標準としてテトラメチルシランを用いたδスケール上)
【0013】
【実験例1】
原料からの分画単離
沖縄県宮古島で自生するBidens pilosa L.var.radiata (和名タチアワユキセンダングサ)を圃場で無農薬栽培し、刈り取った地上部を洗浄、裁断、蒸煮、圧潰、揉解、乾燥工程を経たものを原料とした。原料500gを3.5Lの水で3回、還流下に抽出し、600mLのダイヤイオンHP−20カラムに通して水で洗浄、カラムは50%メタノール、次いでメタノールで溶出した。溶出液の半分を70gのODSカラムに吸着、メタノール/水のメタノールの濃度を順次高めて50%メタノールで十分溶出し、最後にメタノールで溶出した画分を次の実験に供した。
【0014】
【実験例2】
逆相高速液体クロマトグラフィー
カラム:Cosmosil 5ph[5μ、1.0×25cm]、カラム温度30℃
移動相:CH3 CN−1%AcOH[10.5%−60%]、50分、linear gradient、流速2mL/min
検出:UV254nm
得られたHPLCの各ピークをさらにHPLCにかけて精製し、単離した成分の各種スペクトルデータや分解反応生成物の解析から化合物を同定、その構造を決定した。
【0015】
実験例2の結果、A、B、C、A´、B´、C´の化合物が構造決定された。その構造式を図1に示す。
【図1】
得られた化合物の構造式

Figure 0004408612
【0016】
この内、A、B、Cは文献未載の新規化合物で、その1H−及び13C−NMRデータは表1のとおりである。
【表1】
化合物A、B、及びCの1H−及び13C−NMRデータ
Figure 0004408612
【0017】
これらの化合物のNMR以外の特性データは次のとおりである。
【0018】
A:1,2-dihydroxy-5(E)-tridecene-7,9,11-triyne-1-Ο-malony-2-Ο-β-D-glucopyranoside(15-1-Ο-malonate).C22H26O10.SI-MS m/z:451(M+H)+,473(M+Na)+.
【0019】
A-methyl ester:C23H28O10.SI-MS m/z:487(M+Na)+,HR-SI-MS m/z:487.1574(M+Na)+,error:-0.4 m.m.u.[α]D+5.1゜(c=0.19,MeOH).IR(KBr)cm-1:3588,3424(OH),2225(C≡C),1736(COOR),1077,1029(C-O-C).UVλmax(MeOH)nm(logε):329.5(3.75),307.0(3.88),289.0(3.81),272.0(3.59),257.0(3.40),241.0(4.64),234.0(4.62),210.5(4.32).1H-NMRと13C-NMRのシグナルはこの構造と合理的に整合する。
【0020】
B:trideca-5,7,9,11-tetrayn-1,2-diol-1-Ο-malonyl-2-Ο-β-D-glucopyranoside(16-1-Ο-malonate).C22H24O10.SI-MS m/z:471(M+Na)+,487(M+K)+.
【0021】
B-methyl ester:C23H26O10.SI-MS m/z:485(M+Na)+,HR-SI-MS m/z:485.1421(M+Na)+,error:-0.1 m.m.u.[α]D+2.5゜(c=0.10,MeOH).IR(KBr)cm-1:3540,3436(OH),2229(C≡C),1729(COOR),1070,1035(C-O-C).UVλmax(MeOH)nm:329.0(3.45),308.0(3.58),289.0(3.56),273.0(3.47),235.5(4.77),225.0(4.70),215.0(4.47).1H-NMRと13C-NMRのシグナルはこの構造と合理的に整合する。
【0022】
C:tetradeca-6(E)-en-8,10,12-triyn-1,3-diol-1-Ο-malonyl-3-Ο-β-D-glucopyranoside(17-3-Ο-malonate).C23H28O10.SI-MS m/z:465(M+H)+,487(M+Na)+,HR-SI-MS m/z:465.1765(M+H)+,error:0.6 m.m.u.[α]D-28.7゜(c=0.29, MeOH).IR(KBr)cm-1:3446(OH),2223(C≡C),1728(COOH,COOR),1077,1029(C-O-C).UVλmax(MeOH)nm(logε):329.5(3.78),308.0(3.91),289.0(3.86),272.5(3.65),242.0(4.63),233.0(4.58),210.5(4.32).
【0023】
C-methyl ester:C24H30O10.SI-MS m/z:479(M+H)+,501(M+Na)+,HR-SI-MS m/z:479.1917(M+H)+,error:-0.2 m.m.u.[α]D-20.2゜(c=0.25,MeOH).IR(KBr)cm-1:3587,3567,3523(OH),2223(C≡C),1737(COOR),1078,1025(C-O-C).UVλmax(MeOH)nm(logε):329.5(3.83),308.0(3.97),289.0(3.90),272.5(3.70),257.5(2.50),242.0(4.63),232.0(4.61),210.0(4.39).1H-NMRと13C-NMRのシグナルはこの構造と合理的に整合する。
【0024】
【活性評価】
A、B、Cの化合物は、Rosa P.Ubillas et al.[Plant Med.66,82(2000)]が血糖を有意に低下させたと報告した化合物や、Rachel L.C.Pereila et al.[Immunopharmacology 43,31(1999)]が抗炎症効果を裏付けると報告した化合物と構造上極めて近いことから、Bidens pilosa L.の血糖低下作用や抗炎症作用を支える化合物群の一つであることは間違いないことと考えられる。
【0025】
【実施例1】
調製用高速液体クロマトグラフィー装置を用いて実験例1、2と同様の条件で得られた化合物A、B、Cの各画分から減圧濃縮によってメタノールを除き動物実験に供した。4週齢の雄C3Hマウスを対照群、ストレプトゾトシン(STZ)群、試験群4群の各群3匹、計18匹用意し、STZ群と試験群には体重kgあたりSTZ150mgを初日と翌日に腹腔内注射した。対照群とSTZ群は標準飼料を、試験群(A〜C)は標準飼料に上記A、B、Cの画分を、試験群(画分)は実験例1の最後のメタノール溶出画分(減圧下メタノールを除去)を、それぞれ原料(ビデンス・ピローサ加工乾燥物)に換算してマウス体重1kgあたり30g程度の摂取量になるよう混入して自由に摂取させた。2週間後、各群の血糖を測定した所、各群平均値で対照群213、STZ群683、試験群(A)516、試験群(B)476、試験群(C)498、試験群(画分)390mg/dLで、いずれも有意差が認められた。
【0026】
【実施例2】
ボランティア女性3人の左右上腕内側部それぞれ5カ所に、ラウリル硫酸ソーダ10%水溶液を染み込ませたカットバンを5時間貼って発赤を起こさせ、これを除去清拭して後、1カ所は市販の日焼け用クリーム、1カ所は実験例1の最後のメタノール溶出画分、あとの3カ所は実施例1で得た化合物A、B、Cの画分を染み込ませたカットバンを貼って24時間後、48時間後、72時間後に観察したところ、市販の日焼け用クリームは発赤が次第に薄くなるものの最後まで消えなかったが、実験例1のメタノール溶出画分及び化合物A、B、Cの画分ではいずれも1日で発赤が消失していた。すなわち、かなり強力な抗炎症性を示した。[0001]
[Industrial application fields]
The present invention relates to health-useful compounds having hypoglycemic and anti-inflammatory effects.
[Prior art]
[0002]
Diabetes is one of the lifestyle-related diseases, and the patient is a popular disease that is said to have 14.7 million people in Japan including the reserve army. Inflammation is a normal reaction that occurs as part of the body's defense response to invasion, such as infections such as viruses and bacteria, as well as injuries such as trauma and bruises, but it is suppressed therapeutically with fever, pain, swelling, and functional impairment. There is often a need to happen.
[0003]
All of them have been known from the search for natural products and synthetic drugs, and many drugs with excellent hypoglycemic and anti-inflammatory effects have been known. Continues steady in the direction.
SUMMARY OF THE INVENTION Problems to be Solved by the Invention and Means for Solving the Problems
[0004]
The inventors proceeded with the search for plants that are excellent in safety and suitable for these purposes, and were excellent in hypoglycemic action and anti-inflammatory action from plants of the genus Sendangsa already widely used as folklore medicines. By searching for compounds, we intend to provide new hypoglycemic and anti-inflammatory agents.
[0005]
The compound of the present invention is a novel compound that has not been described in the literature and was discovered from Bidens piosa of the Asteraceae family Sendungusa. As described in detail in Japanese Patent Application No. 2000-105559, Asteraceae plants represented by Bidens pilosa are crossed with each other in a wide variety and have many varieties. Although the correspondence between names and Chinese names is also mixed and identification is extremely difficult, the plants of the genus Sendangusa used in the present invention include those listed below.
[0006]
Bidens pilosa L. (Kosendangusa, Koshirono Sendangusa, Sakai Toyokusa)
Bidens pilosa L. var. minor (Blume) Shelf (Shirobana Sendangsa, Silono Sendangsa, Koshiro No Sendangsa, Kosen Dangusa, Sakai Toyokusa)
Bidens pilosa L. var. biseosa Ohtani et Suzuki ( Awayukisendangusa )
Bidens pilosa L. f. decumbens Scherff
Bidens pilosa L. var. radiata Scherff (Tachiawayukisendangusa, may also include Hiawayukisendangusa)
Bidens pilosa L. var. radiata Schultz Bipontinus (Shirono Sendangusa)
Bidens biternata Lour. Merrill et Scherff (Sendangsa)
Bidens bipinnata L. (Kobano Sendangsa, Sendangsa)
Bidens cernua L. (Yanagi Taukogi)
Bidens frontosa L. (American Sendangsa, Seitakatakogi)
Bidens parviflora Wild
Bidens radiata Thuill. var. pinnatifida (Turcz.) Kitamura (Ezonotaukougi)
Bidens tripartita L. (Taukogi)
[0007]
In China and Taiwan, this plant is mainly called 咸咸 草, but there are many synonyms, such as Oji grass, Oni grass, Trefoil needles, Trefoil needles, stab grasses, Acupuncture grasses, White flowers 婆婆 needles, Reed grass There are names such as, Inaba, Nobuno, Akaban, Jinbao Ginban, Fengwei, Nanfugrass, Gong Koan, and the puppet, and it is not clear which scientific name each corresponds to.
[0008]
The flower has a unique shape of the Asteraceae, with several tongue-like flowers like white or yellow round petals and many yellow-brown tubular flowers in the center. Some lack tongue-like flowers. The stem has square and light purple colored nodes. The leaves that are divided into three or five feathers have a pattern, and the edges have jagged edges, often facing each other.
[0009]
In Japan, it is found in the southern part of Honshu, and is distributed in Taiwan, China, the world's subtropics and tropics, and the plant height ranges from 25cm to about 1m. The flowers bloom one after the other. There are needles with inverted spines on the top of dark brown seeds carried on animal and human clothes, and the number of needles is often not constant due to mating. In China, it is called the Genus Genus.
[0010]
Sendungusa plants, especially Bidens pilosa, have been empirically used as a traditional remedy. The whole plant is used for the treatment of diabetes, inflammatory diseases, various digestive diseases, various infectious diseases, rheumatism, etc. Widely used in temperate areas. For example, in Taiwan, it is widely used for acute / chronic appendicitis, nephritis, gastroenteritis, diarrhea, influenza, sore throat, toothache, hepatitis, duodenal inflammation, and is said to have a protective effect on the liver. In Africa, it has been used to treat wounds, severe nausea, stomach pain, constipation, intestinal parasites, dysentery, diarrhea, and abdominal pain. Leaf juice is used for burns, conjunctivitis, otitis, and also as a hemostatic agent. Crushed soup and root dishes are said to work for malaria, and the Zulu people chew shoots to make rheumatic drugs. In China, it is used for enteritis, gonorrhea dysentery, and sore throat. The plant is crushed or decocted to treat wounds and chronic ulcers. Juices are used as eye drops in Central American islands, ulcers in Venezuela and Brazil, and blood pressure in the Andes in Bolivia. It is also used to promote diuresis, bile secretion, and antipyretic fever.
[0011]
The inventors have so much experience in using this plant extract, which is excellent in safety, for human diabetes, hyperlipidemia, atopic dermatitis, hepatitis, intractable summer ulcers in the lower limbs, etc. In particular, the effects were confirmed and the results were confirmed by animal experiments repeatedly. Therefore, various compounds contained in this plant were fractionated, and their isolation and purification were attempted, leading to the discovery of three new compounds. Is.
[0012]
[Measurement equipment]
Ultraviolet spectrum: Shimadzu spectrophotometer UV12008
Red external spectrum: Perkin-Elmer 1720X-FTIE spectrometer MS spectrum: Hitachi M-80 spectrometer NMR spectrum: Varian Mercury 300, and unity Inova-500 (solvent: CDCl 3 , CD 3 OD, and pyridine-d 5 , as internal standard On δ scale using tetramethylsilane)
[0013]
[Experiment 1]
Fraction isolation from raw materials Bidens pilosa L. var. Radiata (Japanese name Tachiawayukisendangusa) that grows naturally in Miyako Island, Okinawa Prefecture, is grown in pesticide-free in the field, and the cut ground parts are washed, cut, cooked, crushed, and dried The raw material was passed through the solution and drying process. 500 g of the raw material was extracted with 3.5 L of water three times under reflux, passed through a 600 mL Diaion HP-20 column, washed with water, and the column was eluted with 50% methanol and then methanol. Half of the eluate was adsorbed on a 70 g ODS column, methanol / water methanol concentration was gradually increased and sufficiently eluted with 50% methanol, and finally the fraction eluted with methanol was subjected to the next experiment.
[0014]
[Experimental example 2]
Reversed phase high performance liquid chromatography column: Cosmosil 5ph [5μ, 1.0 × 25 cm], column temperature 30 ° C.
Mobile phase: CH 3 CN-1% AcOH [10.5% -60%], 50 minutes, linear gradient, flow rate 2 mL / min
Detection: UV254nm
Each peak of the obtained HPLC was further purified by HPLC, the compound was identified from the analysis of various spectrum data of the isolated component and the decomposition reaction product, and the structure was determined.
[0015]
As a result of Experimental Example 2, the structures of the compounds A, B, C, A ′, B ′, and C ′ were determined. Its structural formula is shown in FIG.
[Figure 1]
Structural formula of the obtained compound
Figure 0004408612
[0016]
Among them, A, B, and C are novel compounds not described in literatures, and their 1 H- and 13 C-NMR data are as shown in Table 1.
[Table 1]
1 H- and 13 C-NMR data of compounds A, B, and C
Figure 0004408612
[0017]
The characteristic data other than NMR of these compounds are as follows.
[0018]
A: 1,2-dihydroxy-5 ( E) -tridecene-7,9,11-triyne-1- Ο -malony-2- Ο -β-D-glucopyranoside (15-1- Ο -malonate) .C 22 H 26 O 10 .SI-MS m / z : 451 (M + H) + , 473 (M + Na) + .
[0019]
A-methyl ester: C 23 H 28 O 10 .SI-MS m / z : 487 (M + Na) + , HR-SI-MS m / z : 487.1574 (M + Na) + , error: -0.4 mmu [ α] D + 5.1 ° ( c = 0.19, MeOH) .IR (KBr) cm -1 : 3588,3424 (OH), 2225 (C≡C), 1736 (COOR), 1077,1029 (COC) .UVλ max (MeOH) nm (logε): 329.5 (3.75), 307.0 (3.88), 289.0 (3.81), 272.0 (3.59), 257.0 (3.40), 241.0 (4.64), 234.0 (4.62), 210.5 (4.32). 1 H -NMR and 13 C-NMR signals are reasonably consistent with this structure.
[0020]
B: trideca-5,7,9,11-tetrayn-1,2-diol-1- Ο- malonyl-2- Ο- β-D-glucopyranoside (16-1- Ο- malonate) .C 22 H 24 O 10 .SI-MS m / z : 471 (M + Na) + , 487 (M + K) + .
[0021]
B-methyl ester: C 23 H 26 O 10 .SI-MS m / z: 485 (M + Na) +, HR-SI-MS m / z: 485.1421 (M + Na) +, error: -0.1 mmu [ α] D + 2.5 ° ( c = 0.10, MeOH) .IR (KBr) cm -1 : 3540,3436 (OH), 2229 (C≡C), 1729 (COOR), 1070,1035 (COC) .UVλ max (MeOH) nm: 329.0 (3.45), 308.0 (3.58), 289.0 (3.56), 273.0 (3.47), 235.5 (4.77), 225.0 (4.70), 215.0 (4.47). 1 H-NMR and 13 C-NMR The signal is reasonably consistent with this structure.
[0022]
C: tetradeca-6 ( E ) -en-8,10,12-triyn-1,3-diol-1- Ο- malonyl-3- Ο- β-D-glucopyranoside (17-3- Ο- malonate). C 23 H 28 O 10 .SI-MS m / z : 465 (M + H) + , 487 (M + Na) + , HR-SI-MS m / z : 465.1765 (M + H) + , error: 0.6 mmu [α] D -28.7 ° ( c = 0.29, MeOH) .IR (KBr) cm -1 : 3446 (OH), 2223 (C≡C), 1728 (COOH, COOR), 1077,1029 (COC). UVλ max (MeOH) nm (log ε): 329.5 (3.78), 308.0 (3.91), 289.0 (3.86), 272.5 (3.65), 242.0 (4.63), 233.0 (4.58), 210.5 (4.32).
[0023]
C-methyl ester: C 24 H 30 O 10 .SI-MS m / z : 479 (M + H) + , 501 (M + Na) + , HR-SI-MS m / z : 479.1917 (M + H) + , error: -0.2 mmu [α] D -20.2 ° ( c = 0.25, MeOH) .IR (KBr) cm -1 : 3587,3567,3523 (OH), 2223 (C≡C), 1737 (COOR) UVλ max (MeOH) nm (logε): 329.5 (3.83), 308.0 (3.97), 289.0 (3.90), 272.5 (3.70), 257.5 (2.50), 242.0 (4.63), 232.0 ( 4.61), 210.0 (4.39). The signals of 1 H-NMR and 13 C-NMR are reasonably consistent with this structure.
[0024]
[Activity evaluation]
Compounds of A, B, and C are described in Rosa P. Ubillas et al. [Plant Med. 66 , 82 (2000)] reported a significant reduction in blood glucose, Rachel L. et al. C. Pereila et al. Since [Immunopharmacology 43 , 31 (1999)] is very close in structure to the compound reported to support the anti-inflammatory effect, Bidens pilosa L. et al. It is undoubtedly one of a group of compounds that support the blood glucose lowering action and anti-inflammatory action.
[0025]
[Example 1]
Methanol was removed from each fraction of compounds A, B, and C obtained under the same conditions as in Experimental Examples 1 and 2 using a preparative high performance liquid chromatography apparatus by vacuum concentration, and the mixture was subjected to animal experiments. A total of 18 4-week-old male C3H mice were prepared for each of the control group, streptozotocin (STZ) group, and test group 4 group, and STZ 150 mg / kg body weight was given to the STZ group and test group on the first day and the next day. Internal injection. The control group and the STZ group are the standard feed, the test group (A to C) is the standard feed, and the fractions A, B and C are the standard feed, and the test group (fraction) is the last methanol-eluted fraction of Experimental Example 1 ( Methanol was removed under reduced pressure), and each was mixed and mixed freely so as to obtain an intake amount of about 30 g per kg body weight of the mouse in terms of raw material (processed dried Bidence / Pirosa). Two weeks later, blood glucose of each group was measured. The average value of each group was the control group 213, STZ group 683, test group (A) 516, test group (B) 476, test group (C) 498, test group ( Fraction) Significant difference was observed in all cases at 390 mg / dL.
[0026]
[Example 2]
Applying a cut vane soaked with 10% aqueous solution of sodium lauryl sulfate for 5 hours on each of the inner left and right upper arms of three volunteer women, causing redness, removing and wiping it, then one place is a commercial sunburn Cream for cream, 1 place is the last methanol-eluted fraction of Experimental Example 1, and the other 3 places are pasted with a cut bang soaked with the fractions of Compound A, B, and C obtained in Example 1, 24 hours later, 48 After observing 72 hours later, the commercially available sun cream gradually faded, but did not disappear until the end. However, in the methanol-eluted fraction of Experimental Example 1 and the fractions of compounds A, B, and C, both Redness disappeared in one day. That is, it showed a fairly strong anti-inflammatory property.

Claims (4)

下記構造式A、BまたはCで表される化合物。
(下記構造式A、BまたはCにおいて、「Glc」は「β-D-glucopyranosyl」(β-D-グルコピラノシル)を表す。)
Figure 0004408612
A compound represented by the following structural formula A, B or C.
(In the structural formula A, B or C below, “Glc” represents “β-D-glucopyranosyl” (β-D-glucopyranosyl).)
Figure 0004408612
請求項1記載の化合物を含有する組成物(但し、センダングサ属植物の抽出物の形態を除く)A composition containing the compound according to claim 1 (excluding the form of an extract of the genus Sendangsa) . 請求項1記載の化合物を含有する血糖降下剤。  A hypoglycemic agent comprising the compound according to claim 1. 請求項1記載の化合物を含有する抗炎症剤。  An anti-inflammatory agent comprising the compound according to claim 1.
JP2002245569A 2002-08-26 2002-08-26 New acetylene compounds Expired - Lifetime JP4408612B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2002245569A JP4408612B2 (en) 2002-08-26 2002-08-26 New acetylene compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2002245569A JP4408612B2 (en) 2002-08-26 2002-08-26 New acetylene compounds

Publications (3)

Publication Number Publication Date
JP2004083463A JP2004083463A (en) 2004-03-18
JP2004083463A5 JP2004083463A5 (en) 2005-10-27
JP4408612B2 true JP4408612B2 (en) 2010-02-03

Family

ID=32053725

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002245569A Expired - Lifetime JP4408612B2 (en) 2002-08-26 2002-08-26 New acetylene compounds

Country Status (1)

Country Link
JP (1) JP4408612B2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070053998A1 (en) 2005-09-02 2007-03-08 Academia Sinica Butanol extract of Bidens pilosa
US7763285B2 (en) * 2007-02-12 2010-07-27 Academia Sinica Polyacetylenic compounds
JP5396895B2 (en) * 2009-02-10 2014-01-22 株式会社武蔵野免疫研究所 Anti-obesity agent
CN108553599A (en) * 2018-05-21 2018-09-21 甄生联 Treat the Chinese medicine preparation and formulation method of appendicitis
US20220257684A1 (en) 2019-07-20 2022-08-18 Academia Sinica Anti-coccidial phytogenic formulations

Also Published As

Publication number Publication date
JP2004083463A (en) 2004-03-18

Similar Documents

Publication Publication Date Title
Diallo et al. An ethnobotanical survey of herbal drugs of Gourma district, Mali
Ngbolua A review on the Phytochemistry and Pharmacology of Psidium guajava L.(Myrtaceae) and Future direction
Sharanappa et al. Plant profile, phytochemistry, and pharmacology of Argemone mexicana Linn. A review
Costa et al. Therapeutic potential of Kalanchoe species: flavonoids and other secondary metabolites
Al Muqarrabun et al. A review of the medicinal uses, phytochemistry and pharmacology of the genus Sapium
Shifa et al. Chemical constituents of Rumex abyssinicus roots and evaluation of its antimicrobial activities
Abera et al. Phytochemical investigation the root extract of Syzygium guineense and isolation of 2, 3, 23-trihydroxy methyl oleanate
Awolola et al. The phytochemistry and gastroprotective activities of the leaves of Ficus glumosa
Ashraf et al. Genus Gleditsia: A phytochemical and biological review (2015-2020)
JP4408612B2 (en) New acetylene compounds
Msonthi et al. Kingiside aglucone, a natural secoiridoid from unripe fruits of Strychnos spinosa
Zakaria et al. Ethnobotany, Phytochemistry and Pharmacology of Acanthus ilicifolius: A Comprehensive Review.
Kumar et al. Bryophyllum pinnatum: a review on medicinal benefits and potent bioactive molecules
JP4864252B2 (en) Anti-inflammatory plant component
JP4115777B2 (en) New compounds
Durojaye et al. Two antihyperglycaemic compounds from Globimetula braunii (Engl.) Van Tiegh (Loranthaceae)
Chafamo et al. Phytochemical investigation of the roots extracts of Terminalia brownie and isolation of dimethyl terephthalate
Sikder et al. In vitro antimicrobial screening of four reputed Bangladeshi medicinal plants
Musa et al. Isolation and Characterization of Neoduline from the Rhizome of Dolichos pachyrhizus Harm
CN113429452B (en) A mogrosic acid acylated derivative as an anti-inflammatory agent and an anti-inflammatory composition
Siddiqui et al. Chemical constituents from the stems of Morinda citrifolia Linn
Kikowska et al. Little-known Saniculeae genera: phytochemical studies and pharmaceutical activities
CN116425651A (en) A kind of preparation method of N-alkyl amides compound and its application in anti-inflammatory drug
Tabrea et al. Arctium lappa-a potential source of bioactive compounds with pharmaceutical applications.
El-Din et al. Subfamily Bombacoideae: Traditional Uses, Secondary Metabolites, Biological Activities, and Mechanistic Interpretation of the Anti-Inflammatory Activity of its species

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050825

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20050825

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20050825

RD03 Notification of appointment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7423

Effective date: 20050825

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090511

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090709

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20090709

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20091026

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20091110

R150 Certificate of patent or registration of utility model

Ref document number: 4408612

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20121120

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20131120

Year of fee payment: 4

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term